In the current study, however, we didn’t get similar results of H19 in the chemoresistance of CRC against oxaliplatin, which is also platinum-based drug used extensively for treating colorectal cancer, suggesting that versatile function of H19 in different type of cancer should be considered. The gene discussed is H19; the disease is colorectal carcinoma.